Hasil Pencarian :: Kembali

  1. Beranda
  2. Hasil Pencarian
 Pencarian Spesifik
Ditemukan 8980 dokumen yang sesuai dengan query ::  Simpan CSV
cover
Health Policy and Planning (HPP), Vol.23, No.1, Jan. 2008, hal. 1-13
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
☉
cover
Public Health : Journal of the Royal..., Vol.120, No.9, Sept. 2006, hal. 809-816. ( ket. di bendel No. 8- 12 )
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
☉
cover
World Health Organization
617.742 WOR m
Geneva : WHO, 1996
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
☉
cover
by Cam Donaldson, Miranda Mugford, Luke Vale
330 (610) DON e
[s.l.] : BMJ Books, 2002
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
☉
cover
Cleane Rooney
618.32 ROO a
Geneva : WHO, 1992
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
☉
cover
Workshop on evidence for health policy: burden of disease, Cost-Effectiveness, and health systems (Daftar isi: 1.Expanding the WHO tuberculosis control strategy: rethinking the role active case-finding, C.J.L. Murray; 2. Modeling the impact of global tuberculosis control strategies, ChristopherJ.L. Murray; 3. The decision rules of cost-effectiveness analysis, Goran Karlsson; 4. On the decision relus of cost-effectiveness analysis, Magnus Johannesson; 5. Cost-effectiveness and capital costs, Goran k; 6. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations, Andreas Laupacis; 7. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 8. Cost-effectiveness and cost-benefit analysis of health services: the methodology and its application, A. Griffiths; 9. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, Frank A. Sloan; 10. Cost-benefit analysis (CBA); 11. Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature, Karen B; 12. The use of conjoint analysis to elicit willingness-to-pay values: proceed with caution?, Julie Ratcliffe; 13. Is there a role for benefit-cost analysis in environmental, health, and safety regulation ?, Kenneth J. Arrow; 14. Reasons and persons, Derek Parfit; 15. Qalys and ethics: a health economist's perspective, Alan Williams; 16. Double jeopardy and the use of QALYs in health care allocation, Peter Singer; 17. Double jeopardy, the equal value of lives and the veil of ignorance: a rejoinder to harris, John McKie; 18. The value of DALY life: problems with ethics and validity of disability adjusted life years, Erik Nord; 19. Public preferences for the allocation of donor liver grafts for transplantation, Julie Ratclife; 20. Distributing scarce livers: the moral reasoning of the general public, Peter A. Ubel; 21. Recognizing bedside rationing: clear cases and tough calls, Peter A. Ubel; 22. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial, Mohammad A. Chaudhary; 23. Reflecting uncertainty in cost-effectiveness analysis, W.G. Manning; 24. Hanling uncertanty in economic evaluation, Andrew Briggs; 25. Probabilistic sensitivity analysis in cost-effectiveness: an application from a study of vaccination against pneumococcal bacteremia in the elderly, William Whang; 26. Estimating uncertainty ranges for cost by the bootstrap procedure combined with probabilistic sensitivity analysis, Joanne Lord; 27. Uncertaintyin the economic evaluation of health care technologies: the role of sensitivity analysis, Andrew Briggs; 28. Building uncertainty into cost-effectiveness rankings portofolio risk-return tradeoffs and implications for decision rules, Bernie J. O'Brien; 29. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania, Eric De Jonghe; 30. Linking measures of health gain to explicit priority setting by an area health service in Australia, David A Cromwell; 31. Using discrete choice modelling in priority setting: an application to clinical service developments, Shelley Farrar; 32. Cost-effectiveness analysis and policy choices: investing in health systems, C.J.L. Murray; 33. A cost-effectiveness model for allocating health sector resources, Christopher Murray; 34. Disease control priorities in developing countries: an overview, Dean T. Jamison; 35. Oregon's medicaid ranking and cost-effectiveness: is there any relationship ?, Tammy O. Tengs; 36. Five-hundred life-saving interventions and their cost-effectiveness, Tammy O. Tengs; 37. Prioritising health services in an era of limits: the Oregon experience, John A Kitzhaber; 38. Priority setting: lessons from Oregon, Jennifer Dixon; 39. Oregon's methods: did cost-effectiveness analysis fail?; 40.
P 362.1 WOR w
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding   Pusat Informasi Kesehatan Masyarakat
☉
cover
Health Policy and Planning, Vol.22, No.5, Sept. 2007, hal. 303-310
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
☉
cover
Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Foundations of cost-effectiveness analysis for health and medical practices, Milton C. Weinsrein; StasonWilliam B.; 2. Cost-effectiveness analysis: an introductory guide for clinicians, Marcones, George A; 3. Developmentof WHO guidelines on generalized cost-effectiveness analysis, Murray, Christopher J.L; (et al); 4. Cost analysis in primary health care: a training manual for programme managers, Andrew Creese; 5. Public hospitals in developing countries: resource use, cost, financing, Howard Barnum; 6. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 7. National price levels and the prices of tradables and nontradables, Irving B. Kravis; 8. For here or to go ? Purchasing power parity and the big mac, Michael R. Pakko; 9. Cost-analysis: issues and methodologies, Anandarup Ray; 10. THe Penn World Table (PWT) estimates of purchasing power parities and consumption, invesment, and governt price parities for non-benchmark countries (with special reference to PWT 5.6), Alan Heston; 11. The real and nominal? making inflationary adjusments to cost and other economic data, Lilani Kumaranayake; 12. Discounting human lives, Maureen L Cropper; 13. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 14. Time preference, J. Lipscomp; 15. Time preference in medical making and cost-effectiveness analysis , Donald A Redelmier; 15. Discounting costs and effects: a reconsideration, Ben A. Van Hout; 16. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, FRank A. Sloan; 17. Standardizing methodologies for economic evaluation in health care: practice, problems, and potential, Michael Drummond; 18. How much does excess inpatient capacity really cost ?, Parves R. Sopariwala; 19. Applying ABC to healthcare: as rising costs impact managed care, a successful manufacturing costing method is being applied to help managers make decisions on capitation contract bidding, cost containment, and organizational structure, Twothy D. West; 20.. IMCI multi-country evaluation form 5 A: health facility costs questionnaire; 21. The usefulness of rations for allocation decisions: the case of stroke, A. Ament; 22. A review of the use of health status measures in economic evaluation, J Brazier; 23. Preference-based measures in economic evaluation in health care, Peter J. Neumann; 24. Multi-aatribute preference functions: health utilities index, George W. Torrance; 25. Utilities and quality-adjusted life years, George W. Torrance; 26. Disability-adjusted life years: a critical review, Sudhir anand; 27. Understanding DALYs, Christopher J.L. Murray; 28. QALYs, HYEs and individualpreferences - a graphical illustration, Magnus Johannesson; 29. What randomized trials and systematic reviews can offer decision makers, Douglas G. Altman; 30. Evaluation of health interventions at area and organisation level, Obioha C Ukoumunne; 31. Interpreting the evidence: choosing between randomised and non-randomised studis, Martin McKee; 32. An evidence based approach to individualising treatment, Paul P. Glasziou; 33. Efficacy and effectiveness issues in the NIDA cooperative agreement: interventions for out-of-teatment drug-users; 34. The practice of antenatal care: comparing four study sites in different parts of the world participating in the WHO antenatal care rondomized controlled trial, Gilda Piaggio; 35. Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease, Thommas A. Pearson)
P 362.1 WOR w
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding   Pusat Informasi Kesehatan Masyarakat
☉
cover
Kesmas ( Jur. Kesmasnas ), Vo. 7, No.5, Des. 2012: hal. 193-194
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
☉
cover
Health Policy and Planning ( HPP ), Vol.28.No.6, Sept. 2013, hal : 596-605
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
☉
:: Pengguna : Pusat Informasi Kesehatan Masyarakat
Library Automation and Digital Archive